Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shannon, K. M.
Right arrow Articles by Priest, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shannon, K. M.
Right arrow Articles by Priest, J. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis

KM Shannon, J Watterson, P Johnson, P O'Connell, B Lange, N Shah, P Steinherz, YW Kan and JR Priest

Department of Pediatrics, Naval Hospital, Oakland, CA 94627.

Loss of constitutional heterozygosity is a common molecular feature of cancers in which inactivation of one or more tumor suppressor genes is thought to contribute to tumorigenesis. Recent evidence suggests that the gene responsible for neurofibromatosis, type 1 (NF-1), belongs to this class of heritable cancer genes. Children with NF-1 show an increased incidence of myeloid leukemia, including juvenile chronic myelogenous leukemia (JCML) and, perhaps, the myeloproliferative syndrome (MPS) associated with bone marrow monosomy 7 (Mo 7). We have investigated five children with Mo 7: three with NF-1 and two others with suggestive evidence of NF-1. Southern blotting experiments performed in four patients showed no loss of heterozygosity in bone marrow specimens using probes linked to the NF-1 locus on the long arm of chromosome 17. Both of our patients with familial NF-1 inherited the disease from their mothers, as did 14 of 19 other cases of myeloid leukemia in children with familial NF-1. Seventeen of these 21 children were boys. Myeloid leukemia developed in 12 boys and four girls who inherited NF-1 from their mothers, and in five boys who inherited the disease from their fathers. Father-to-daughter transmission was not observed. Taken together, the presence of chromosome 7 deletions in the leukemias of children with NF-1, a pattern of inheritance favoring maternal transmission of NF-1, and the marked predilection for boys to develop JCML and Mo 7 suggest a multistep mechanism of oncogenesis in which epigenetic factors might play a role. Further investigation is required to determine if the NF-1 genes in the leukemic bone marrows of these patients have acquired point mutations or small deletions.

Volume 79, Issue 5, pp. 1311-1318, 03/01/1992
Copyright © 1992 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
A. Theos and B. R. Korf
Pathophysiology of neurofibromatosis type 1.
Ann Intern Med, June 6, 2006; 144(11): 842 - 849.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Hiatt, D. A. Ingram, H. Huddleston, D. F. Spandau, R. Kapur, and D. W. Clapp
Loss of the Nf1 Tumor Suppressor Gene Decreases Fas Antigen Expression in Myeloid Cells
Am. J. Pathol., April 1, 2004; 164(4): 1471 - 1479.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. L. Loh, S. Vattikuti, S. Schubbert, M. G. Reynolds, E. Carlson, K. H. Lieuw, J. W. Cheng, C. M. Lee, D. Stokoe, J. M. Bonifas, et al.
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
Blood, March 15, 2004; 103(6): 2325 - 2331.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. A. Ingram, L. Zhang, J. McCarthy, M. J. Wenning, L. Fisher, F.-C. Yang, D. W. Clapp, and R. Kapur
Lymphoproliferative defects in mice lacking the expression of neurofibromin: functional and biochemical consequences of Nf1 deficiency in T-cell development and function
Blood, November 15, 2002; 100(10): 3656 - 3662.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. M. Blaydes, S. C. Kogan, B.-T. H. Truong, D. J. Gilbert, N. A. Jenkins, N. G. Copeland, D. A. Largaespada, and C. I. Brannan
Retroviral Integration at the Epi1 Locus Cooperates with Nf1 Gene Loss in the Progression to Acute Myeloid Leukemia
J. Virol., October 1, 2001; 75(19): 9427 - 9434.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. D. Emanuel, R. C. Snyder, T. Wiley, B. Gopurala, and R. P. Castleberry
Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors
Blood, January 15, 2000; 95(2): 639 - 645.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Mahgoub, B. R. Taylor, M. M. L. Beau, M. Gratiot, K. M. Carlson, S. K. Atwater, T. Jacks, and K. M. Shannon
Myeloid Malignancies Induced by Alkylating Agents in Nf1 Mice
Blood, June 1, 1999; 93(11): 3617 - 3623.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Luna-Fineman, K. M. Shannon, S. K. Atwater, J. Davis, M. Masterson, J. Ortega, J. Sanders, P. Steinherz, V. Weinberg, and B. J. Lange
Myelodysplastic and Myeloproliferative Disorders of Childhood: A Study of 167 Patients
Blood, January 15, 1999; 93(2): 459 - 466.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. E. Side, P. D. Emanuel, B. Taylor, J. Franklin, P. Thompson, R. P. Castleberry, and K. M. Shannon
Mutations of the NF1 Gene in Children With Juvenile Myelomonocytic Leukemia Without Clinical Evidence of Neurofibromatosis, Type 1 
Blood, July 1, 1998; 92(1): 267 - 272.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
Y.-Y. Zhang, T. A. Vik, J. W. Ryder, E. F. Srour, T. Jacks, K. Shannon, and D. Wade Clapp
Nf1 Regulates Hematopoietic Progenitor Cell Growth and Ras Signaling in Response to Multiple Cytokines
J. Exp. Med., June 1, 1998; 187(11): 1893 - 1902.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Arico, A. Biondi, and C.-H. Pui
Juvenile Myelomonocytic Leukemia
Blood, July 15, 1997; 90(2): 479 - 488.
[Full Text] [PDF]


Home page
NEJMHome page
L. Side, B. Taylor, M. Cayouette, E. Conner, P. Thompson, M. Luce, and K. Shannon
Homozygous Inactivation of the NF1 Gene in Bone Marrow Cells from Children with Neurofibromatosis Type 1 and Malignant Myeloid Disorders
N. Engl. J. Med., June 12, 1997; 336(24): 1713 - 1720.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C.M. Niemeyer, M. Arico, G. Basso, A. Biondi, A. C. Rajnoldi, U. Creutzig, O. Haas, J. Harbott, H. Hasle, G. Kerndrup, et al.
Chronic Myelomonocytic Leukemia in Childhood: A Retrospective Analysis of 110 Cases
Blood, May 15, 1997; 89(10): 3534 - 3543.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
K. M. Shannon, P. O'Connell, G. A. Martin, D. Paderanga, K. Olson, P. Dinndorf, and F. McCormick
Loss of The Normal NF1 Allele from the Bone Marrow of Children with Type 1 Neurofibromatosis and Malignant Myeloid Disorders
N. Engl. J. Med., March 3, 1994; 330(9): 597 - 601.
[Abstract] [Full Text]


Home page
NEJMHome page
G. M. Brodeur
The NF1 Gene in Myelopoiesis and Childhood Myelodysplastic Syndromes
N. Engl. J. Med., March 3, 1994; 330(9): 637 - 639.
[Full Text]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1992 by American Society of Hematology         Online ISSN: 1528-0020